Tygacil gains indication for community-acquired bacterial pneumonia in adults - MPR
Links shared publicly online about this topic.
- 2,164total visits
Tygacil gains indication for community-acquired bacterial pneumonia in adults - MPR
empr.com —
Tygacil (tigecycline, from Wyeth) has been FDA approved for the treatment of adult patients with community-acquired bacterial pneumonia (CABP) caused by susceptible strains of indicated pathogens.
View full resource at empr.com
Tags: Pneumonia, Bacterial Pneumonia, FDA, Wyeth
Most Recently Shared on March 25, 2009 at 2:47 pm By:
Tygacil gains indication for community-acquired bacterial pneumonia in adults: Tygacil (tigecycline, from Wyeth).. http://tinyurl.com/cgcl2n
Advertisement
